229 related articles for article (PubMed ID: 34174487)
1. Photodynamic therapy of cutaneous T-cell lymphoma cell lines mediated by 5-aminolevulinic acid and derivatives.
Vallecorsa P; Di Venosa G; Gola G; Sáenz D; Mamone L; MacRobert AJ; Ramírez J; Casas A
J Photochem Photobiol B; 2021 Aug; 221():112244. PubMed ID: 34174487
[TBL] [Abstract][Full Text] [Related]
2. Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapy.
Rodriguez L; de Bruijn HS; Di Venosa G; Mamone L; Robinson DJ; Juarranz A; Batlle A; Casas A
J Photochem Photobiol B; 2009 Sep; 96(3):249-54. PubMed ID: 19646894
[TBL] [Abstract][Full Text] [Related]
3. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy.
Casas A; Fukuda H; Di Venosa G; Batlle A
Br J Cancer; 2001 Jul; 85(2):279-84. PubMed ID: 11461090
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.
Zhang J; Yuan S; Fan M; Wang K; Guo J; Zang A; Ren J; Su W; Zhang C; Xie Y
Bioorg Med Chem; 2024 May; 105():117726. PubMed ID: 38626642
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic effects of 5-aminolevulinic acid and its hexylester on several cell lines.
Wu SM; Ren QG; Zhou MO; Wei Y; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):655-60. PubMed ID: 12883637
[TBL] [Abstract][Full Text] [Related]
6. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
7. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
8. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy.
Casas A; Batlle A
Curr Med Chem Anticancer Agents; 2002 Jul; 2(4):465-75. PubMed ID: 12678731
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of normal and malignant human lymphocytes to 5-aminolevulinic acid-mediated photodynamic damage.
Gamaleia NF; Shishko ED; Gluzman DF; Sklyarenko LM
Exp Oncol; 2008 Mar; 30(1):65-9. PubMed ID: 18438344
[TBL] [Abstract][Full Text] [Related]
10. Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease.
Rodriguez L; Vallecorsa P; Battah S; Di Venosa G; Calvo G; Mamone L; Sáenz D; Gonzalez MC; Batlle A; MacRobert AJ; Casas A
Photochem Photobiol Sci; 2015 Sep; 14(9):1617-27. PubMed ID: 26066768
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 5-aminolevulinic acid and its hexylester mediated photodynamic action on human hepatoma cells.
Ren QG; Wu SM; Peng Q; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):650-4. PubMed ID: 12198571
[TBL] [Abstract][Full Text] [Related]
12. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
13. The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis.
Kelty CJ; Brown NJ; Reed MW; Ackroyd R
Photochem Photobiol Sci; 2002 Mar; 1(3):158-68. PubMed ID: 12659511
[TBL] [Abstract][Full Text] [Related]
14. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA).
Rittenhouse-Diakun K; Van Leengoed H; Morgan J; Hryhorenko E; Paszkiewicz G; Whitaker JE; Oseroff AR
Photochem Photobiol; 1995 May; 61(5):523-8. PubMed ID: 7770514
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.
Orenstein A; Haik J; Tamir J; Winkler E; Trau H; Malik Z; Kostenich G
Dermatol Surg; 2000 Aug; 26(8):765-9; discussion 769-70. PubMed ID: 10940064
[TBL] [Abstract][Full Text] [Related]
16. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.
Perotti C; Fukuda H; DiVenosa G; MacRobert AJ; Batlle A; Casas A
Br J Cancer; 2004 Apr; 90(8):1660-5. PubMed ID: 15083200
[TBL] [Abstract][Full Text] [Related]
17. Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives.
Fotinos N; Convert M; Piffaretti JC; Gurny R; Lange N
Antimicrob Agents Chemother; 2008 Apr; 52(4):1366-73. PubMed ID: 18195063
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
Abels C; Fritsch C; Bolsen K; Szeimies RM; Ruzicka T; Goerz G; Goetz AE
J Photochem Photobiol B; 1997 Aug; 40(1):76-83. PubMed ID: 9301046
[TBL] [Abstract][Full Text] [Related]
19. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
20. The use of dipeptide derivatives of 5-aminolaevulinic acid promotes their entry to tumor cells and improves tumor selectivity of photodynamic therapy.
Di Venosa G; Vallecorsa P; Giuntini F; Mamone L; Batlle A; Vanzuli S; Juarranz A; MacRobert AJ; Eggleston IM; Casas A
Mol Cancer Ther; 2015 Feb; 14(2):440-51. PubMed ID: 25519699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
